Perinatal group B streptococcal disease prevention, Minnesota

Area of Science:

• Obstetrics and Gynecology
• Infectious Disease Prevention
• Neonatal Health

Background:

• Perinatal group B streptococcal (GBS) disease poses a significant risk to newborns.
• Previous prevention strategies have evolved over time.
• Updated guidelines aim to reduce GBS transmission during childbirth.

Purpose of the Study:

• To assess the adoption and implementation of revised guidelines for preventing perinatal GBS disease in Minnesota.
• To evaluate changes in provider practices regarding GBS screening and prevention since 1998.

Main Methods:

• A survey of Minnesota healthcare providers was conducted in 2002.
• The survey focused on the use of prevention policies and screening methods for GBS.
• Data collection specifically targeted the timing of vaginal and rectal specimen screening.

Main Results:

• All surveyed Minnesota providers reported utilizing a GBS prevention policy in 2002.
• The majority of providers screen vaginal and rectal specimens between 34-37 weeks of gestation.
• There has been a dramatic increase in the utilization of screening-based GBS prevention methods compared to 1998.

Conclusions:

• Revised guidelines for preventing perinatal GBS disease have been widely adopted by Minnesota providers.
• Screening at 34-37 weeks gestation is the predominant method employed.
• The trend indicates a successful implementation and increased adherence to evidence-based prevention strategies.